Comparison of Semen Quality Before and After Inactivated SARS-CoV-2 Vaccination Among Men in China
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.30631
Abstract: This cohort study examines changes in semen quality—including semen volume, sperm concentration, total sperm count, and total and progressive sperm motility—before and after inactivated SARS-CoV-2 vaccination among men in China. read more here.
Keywords: semen quality; vaccination among; among men; inactivated sars ... See more keywords
A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of medical virology"
DOI: 10.1002/jmv.27334
Abstract: Neutralizing antibodies in volunteers who received two doses of an inactivated SARS-CoV-2 vaccine deceased over several months. A three-dose procedure study suggested that the boost conferred by a third dose rescued the waning of neutralizing… read more here.
Keywords: cov vaccine; sars cov; doses inactivated; booster dose ... See more keywords
Comparison of immune responses induced by two or three doses of an alum‐adjuvanted inactivated SARS‐CoV‐2 vaccine in mice
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.27637
Abstract: Waning antibodies and rapidly emerging variants are challenges for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccine development. Adjusting existing immunization schedules and further boosting strategies are under consideration. Here, the immune responses induced by… read more here.
Keywords: inactivated sars; adjuvanted inactivated; alum adjuvanted; schedule ... See more keywords
Stable and durable antibody responses in SARS‐recovered donors vaccinated with inactivated SARS‐CoV‐2 vaccine
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28662
Abstract: Whether the immune imprinting caused by severe acute respiratory syndrome coronavirus (SARS‐CoV) affects the efficiency of SARS‐CoV‐2 vaccination has attracted global concern. Little is known about the dynamic changes of antibody response in SARS convalescents… read more here.
Keywords: sars recovered; inactivated sars; recovered donors; sars cov ... See more keywords
Dynamic immunogenicity after primary and booster inactivated SARS‐CoV‐2 vaccination in people living with HIV: A longitudinal observational study
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28730
Abstract: People living with HIV (PLWH) have poor outcomes from severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2); vaccination reduces the associated mortality. The humoral immune response dynamics after booster inactivated vaccinations in PLWH remain unclear. In… read more here.
Keywords: booster inactivated; vaccination; inactivated sars; cov vaccination ... See more keywords
Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study
Sign Up to like & getrecommendations! Published in 2022 at "EClinicalMedicine"
DOI: 10.1016/j.eclinm.2021.101226
Abstract: Background Inactivated COVID-19 vaccines are safe and effective in the general population with intact immunity. However, their safety and immunogenicity have not been demonstrated in people living with HIV (PLWH). Methods 42 HIV-1 infected individuals… read more here.
Keywords: people living; non randomized; living hiv; cell ... See more keywords
Inactivated SARS-CoV-2 vaccine for people with HIV
Sign Up to like & getrecommendations! Published in 2022 at "EClinicalMedicine"
DOI: 10.1016/j.eclinm.2022.101327
Abstract: eClinicalMedicine 2022;45: 101327 Published online xxx https://doi.org/10.1016/j. eclinm.2022.101327 HIV patients are at increased risk of COVID-19 morbidity and mortality. Moreover, increased SARS-CoV-2 mutation development has been reported in (African) HIV-1 infected patients. Previous reports documented… read more here.
Keywords: hiv infected; cov vaccine; safety immunogenicity; sars cov ... See more keywords
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18–59 years: A phase I randomized, double-blinded, controlled trial
Sign Up to like & getrecommendations! Published in 2021 at "Vaccine"
DOI: 10.1016/j.vaccine.2021.04.006
Abstract: Background This study examined the safety and immunogenicity of an inactivated SARS-CoV-2 vaccine. Method In a phase I randomized, double-blinded, placebo-controlled trial involving 192 healthy adults 18-59 years old, two injections of three doses (50… read more here.
Keywords: trial; cov vaccine; safety immunogenicity; sars cov ... See more keywords
Absence of active systemic anaphylaxis in guinea pigs upon intramuscular injection of inactivated SARS-CoV-2 vaccine (Vero cells)
Sign Up to like & getrecommendations! Published in 2022 at "Immunopharmacology and Immunotoxicology"
DOI: 10.1080/08923973.2022.2073889
Abstract: Abstract Background: The safety of novel vaccines against COVID-19 is currently a major focus of preclinical research. As a part of the safety evaluation testing package, 24 healthy guinea pigs were used to determine whether… read more here.
Keywords: injection; inactivated sars; guinea pigs; vaccine ... See more keywords
Pemphigus foliaceus triggered after inactivated SARS‐CoV‐2 vaccine: Coincidence or causal link?
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15775
Abstract: Pemphigus is a group of autoimmune blistering disorders associated with autoantibodies against the keratinocyte cell surface. Its exact cause is still unknown, but neoplasms, infections, medications, or vaccines are considered as possible triggering factors. Only… read more here.
Keywords: inactivated sars; triggered inactivated; sars cov; pemphigus foliaceus ... See more keywords
Cutaneous reactions to inactivated SARS‐CoV‐2 vaccine and ChAdOx1‐S (recombinant) vaccine against SARS‐CoV‐2: a case series from the Philippines
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.17575
Abstract: The Philippines remains one of the countries with the highest number of new COVID-19 cases in the Western Pacific region. The Philippine government granted emergency use authorizations for inactivated SARS-COV-2 (Sinovac) and recombinant ChAdOx1-S (AstraZeneca)… read more here.
Keywords: chadox1; vaccine; sars cov; reactions inactivated ... See more keywords